Successful Treatment of Mucous Membrane Pemphigoid with Dupilumab: A Case Report
DOI:
https://doi.org/10.2340/actadv.v104.40162Keywords:
Mucous membrane pemphigoid, dupilumab, Biologics, pemphigoidAbstract
Abstract is missing (Short communication)
Downloads
References
Du G, Patzelt S, van Beek N, Schmidt E. Mucous membrane pemphigoid. Autoimmun Rev 2022; 21: 103036.
https://doi.org/10.1016/j.autrev.2022.103036 DOI: https://doi.org/10.1016/j.autrev.2022.103036
Rashid H, Lamberts A, Borradori L, Alberti-Violetti S, Barry RJ, Caproni M, et al. European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I. J Eur Acad Dermatol Venereol 2021; 35: 1750-1764.
https://doi.org/10.1111/jdv.17397 DOI: https://doi.org/10.1111/jdv.17397
Olbrich H, Sadik CD, Schmidt E. Autoimmune blistering diseases: promising agents in clinical trials. Expert Opin Investig Drugs 2023; 32: 615-623.
https://doi.org/10.1080/13543784.2023.2242778 DOI: https://doi.org/10.1080/13543784.2023.2242778
Russo R, Cozzani E, Gasparini G, Parodi A. Targeting interleukin 4 receptor α: a new approach to the treatment of cutaneous autoimmune bullous diseases? Dermatol Ther 2020; 33: e13190.
https://doi.org/10.1111/dth.13190 DOI: https://doi.org/10.1111/dth.13190
Rashid H, Meijer JM, Bolling MC, Diercks GFH, Pas HH, Horváth B. Insights into clinical and diagnostic findings as well as treatment responses in patients with mucous membrane pemphigoid: a retrospective cohort study. J Am Acad Dermatol 2022; 87: 48-55.
https://doi.org/10.1016/j.jaad.2021.11.061 DOI: https://doi.org/10.1016/j.jaad.2021.11.061
Schmidt E, Rashid H, Marzano AV, Lamberts A, Di Zenzo G, Diercks GFH, et al. European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II. J Eur Acad Dermatol Venereol 2021; 35: 1926-1948.
https://doi.org/10.1111/jdv.17395 DOI: https://doi.org/10.1111/jdv.17395
Russo R, Capurro N, Cozzani E, Parodi A. Use of dupilumab in bullous pemphigoid: where are we now? J Clin Med 2022; 11: 3367.
https://doi.org/10.3390/jcm11123367 DOI: https://doi.org/10.3390/jcm11123367
Raef HS, Elmariah SB. Successful treatment of Brunsting-Perry cicatricial pemphigoid with dupilumab. J Drugs Dermatol 2021; 20: 1113-1115.
Maloney NJ, Tegtmeyer K, Zhao J, Worswick S. Dupilumab in dermatology: potential for uses beyond atopic dermatitis. J Drugs Dermatol 2019; 18: S1545961619P1053X.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Zhiyi Wang, Xiaojing Liu, Jing Ni, Yushuo Qi, Zhiqi Song, Yongjun Piao
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
